Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5562 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 10 11 12 ... 54 55 56  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Batavia–UGA Biopharma: cell line development, –201708 collab devleopm of 2 enzmye expressing monoclonal cell lines for biopharma production 2017-08-22
CRISPR Therapeutics–Partners HealthCare: cell therapy, 201708– collab research + license option 2y w MGHCC develop cancer T cell therapies w CRISPR 2017-08-22
Lilly–Topas Therapeutics: immuno modulatory compounds, 201708– collab €na multi-y research + option agreem 2017-08-22
Micro-Sphere–Ramarketing: public relations, 201708– service by Ramarketing 2017-08-22
AstraZeneca–Ethris: mRNA-based therapeutics, 201708– collab research 5y w €25m upfront + funding + milestones using SNIM®RNA technology 2017-08-21
Ethris–MacDougall Biomedical Communications: public relations, 201708 service existent by MacDougall 2017-08-21
Rodos BioTarget–SEVERAL: investment, 201708 capital increase €800k via crowdfunding platform Aescuvest 2017-08-18
Biotecon–Bruker Corp: mass spectrometer, 201708– distribution OEM of MALDI Biotyper platforms for food analysis in DACH region + Eastern Europe 2017-08-16
Monsanto–ToolGen: CRISPR technology, 201708– license ww €na for use of ToolGen’s CRISPR technology platform in agricultural products 2017-08-16
Roche–Mimetas: organ-on-a-chip technology, –201708 collab developm gut model on-a-chip using OrganoPlate platform 2017-08-16
Purdue Pharma–CellAct: cancer drug, 201708– acquisition ww developm + commerc rights to CAP7.1 by Mundipharma from CellAct 2017-08-14
Roivant–SEVERAL: investment, 201708 financing round $1.1b led by SoftBank Vision Fund + incl Dexxon investor group 2017-08-09
Roivant–SoftBank: investment, 201708 financing round totalling $1.1b incl new + lead investor SoftBank Vision Fund 2017-08-09
Diagnosticum (HU)–Bruker Corp: food analysis, 201708 collab to form Hungarian Wine Consortium using NMR FoodScreener for wine analysis 2017-08-08
IFM Therapeutics–BMS: investment, 201708– acquisition 100% for $300m upfront + up to $2.02b milestones 2017-08-03
Bruker Corp–OTHER: immunoassay technology, 201708 acquisition €na of portable chip-based ELISA platform by Bruker 2017-08-02
Homology Medicines–HBM: investment, 201708 financing round Series B totalling $83.5m incl new + co-investor HBM Healthcare Investments 2017-08-01
Homology Medicines–Novartis: investment, 201708 financing round Series B totalling $83.5m incl new + co-investor Novartis 2017-08-01
Homology Medicines–SEVERAL: investment, 201708 financing round Series B $83.5m led by Deerfield Management 2017-08-01
Lyocontract–Lyomark Pharma: investment, 201708 acquisition of majority share in Lyocontract GmbH by Lyomark Pharma GmbH 2017-08-01
Aptuit–Evotec: investment, 201707–201708 acquisition $300m in cash of Aptuit from Welsh, Carson, Anderson & Stowe 2017-07-30
Evoxx Technologies–Advanced Enzyme Technologies: investment, 201707– acquisition 100% by Advanced Enzymes ANNOUNCED 2017-07-28
Protembis–Germany (govt): grant, 201507 BMBF grant 7-digit € for Protembis in collab with RWTH Aachen 2017-07-28
Evosciences–Danaher: mass spectrometer, 201707– distribution of Sciex MS systems with flexible finacing packages via Evosciences in Europe 2017-07-27
Genkyotex–Alize RP: public relations, 201707 service existent media relations by Alize RP 2017-07-27
Genkyotex–LifeSci: public relations, 201707 service existent in US by LifeSci Advisors 2017-07-27
Genkyotex–NewCap: public relations, 201707 service existent IR by NewCap 2017-07-27
JnJ–Proteros: drug discovery services, 201707– collab €na lead discovery small molecule cancer drugs using NEAT for Jannsen Biotech 2017-07-27
stimOS–Baden-Württemberg (govt): investment, 201707 seed financing round totalling €720k from HTGF + MBG Baden-Württemberg 2017-07-27
stimOS–High-Tech Gründerfonds: investment, 201707 seed financing round totalling €720k from HTGF + MBG Baden-Württemberg 2017-07-27
stimOS–SEVERAL: investment, 201707 seed financing round €720k from HTGF + MBG Baden-Württemberg 2017-07-27
Storm Therapeutics–Evotec: drug discovery services, 201707– supply service expansion €na HTS + structural biology plus chemistry + new targets 2017-07-27
Jazz Pharmaceuticals–XL-protein: PASylation technology, 201707– license $2m upfront + funding + milestones + royalties to develop asparaginase drugs 2017-07-26
Micro-Macinazione–Lonza: investment, 201707 acquisition €na of Micro-Macinazione from Cross Equity Fund 2017-07-26
DiaSorin–Siemens: ELISA immunoassays, 201707– acquisition up to €47.5m of Siemens ELISA Dx portfolio/assets without employees + mftg capacity 2017-07-25
Protembis–Germany (govt): business development, 201707– supply service support in US with German Accelerator Life Sciences programme 2017-07-25
Bayer–Evotec: drug discovery services, 201707–201812 collab extension endometriosis alliance after reaching milestone of start of phase 1 2017-07-24
Boehringer–Philogen: drug discovery services, 201707– collab €na discovery + optimisation of small molecule drugs using ESAC technology 2017-07-20
Spindiag–SEVERAL: investment, 201707 seed financing round €1.6m from three private investors 2017-07-20
Humabs BioMed–MC Services: public relations, 201707 service existent by MC Services AG 2017-07-18
Maruho–4SC: Kv1.3 inhibitors, 201707– license ww excl for up to total €208m upfront + milestones plus single-digit royalties 2017-07-18
Shire–Novimmune: therapeutic antibodies, 201707– license ww excl €na to bispecific antibody for hemophilia A 2017-07-18
TomTec Imaging–Philips: investment, 201707– acquisition €na of TomTec Imaging Systems GmbH by Philips ANNOUNCED 2017-07-18
BASF–Kaiima: plant biotechnology, 201707– collab research multi-year using EP technology to discover herbicide resistent traits 2017-07-17
Diagenode–PreOmics: proteomic sample preparation, –201707 collab developm combi of Bioruptor + iST Kit to clean peptides for MS 2017-07-14
NofaGroup–Cotecna: investment, 201707 acquisition of NofaGroup by Cotecna Inspection SA 2017-07-13
ABF–Genedata: bioinformatics, 201707– supply expansion use of Genedata Selector by AB Enzymes for decision support 2017-07-11
Blueprint Genetics–Creathor Venture: investment, 201707 financing round totalling up to €14m incl new + co-lead investor Creathor Venture 2017-07-11
Blueprint Genetics–Inventure: investment, 201707 financing round totalling up to €14m incl existing + co-investor Inventure 2017-07-11
Blueprint Genetics–MedTech Innovation Partners: investment, 201707 financing round totalling up to €14m incl new + co-lead investor MTIP 2017-07-11
Blueprint Genetics–Pontos Group: investment, 201707 financing round totalling up to €14m incl existing + co-investor Pontos Group 2017-07-11
Blueprint Genetics–SEVERAL: investment, 201707 financing round up to €14m led by Creathor Venture + MTIP + incl Inventure + Pontos Group 2017-07-11
Nestlé–Enterome: diagnostics, 201707– collab establishm of 50/50 jv MDP to develop microbiome-based diagnostics except for immuno-oncology 2017-07-11
CRISPR Therapeutics–Neon Therapeutics: T cell therapy, 201707– collab combi of proprietary technologies to develop T cell therapies 2017-07-10
Endress+Hauser–GUS Group: investment, 201707 acquisition of AJ Blomesystem GmbH by GUS Group 2017-07-01
Evotec–Hamburg (govt): grant, 201707– 201906 RnD grant from IFB Hamburg to develop AB-based cancer therapies with UKE 2017-07-01
Global Bioenergies–SEVERAL: investment, 201706 capital increase €10.24m via private placement of 640k new shares at €16/share 2017-06-30
mySugr–Roche: investment, 201706 acquisition of remaining shares by Roche 2017-06-30
Evotec–Censo Biotechnologies: stem cell technology, 201706–201905 strategic collab €na with Censo supplying iPS cell lines to Evotec 2017-06-28
Indi Molecular–Merck (DE): investment, 201706 financing round Series A totalling $11.5m led by Merck Ventures + Legend Capital 2017-06-28
Indi Molecular–SEVERAL: investment, 201706 financing round Series A $11.5m led by Merck Ventures + Legend Capital 2017-06-28
BioGeneration Ventures–EU (govt): investment, 201706 investment by EIF + other new investors bringing total capital of BGV III to €66m 2017-06-27
BioGeneration Ventures–SEVERAL: investment, 201706 investm by EIF + other new investors bringing total capital of BGV III to €66m with max target €75m 2017-06-27
CatalYm–BioGeneration Ventures: investment, 201706 CatalYm GmbH is existent investment of BGV III fund 2017-06-27
Sensovation–Miltenyi Biotec: investment, 201706 acquisition by Milteny from HeidelbergCapital + KfW/tbg 2017-06-27
Takeda–JSR Corp: cell line development, 201706– commercial license to use Selexis’ SUREtechnology for developm of fusion proteins 2017-06-27
Ottobock–EQT: investment, 201706 EQT VII fund to acquire 20% stake from Otto Bock HealthCare GmbH valuing Ottobock at €3.15b 2017-06-24
DiaSorin–Qiagen: in vitro diagnostics, 201706– collab to adopt select Qiagen assays for use on Liaison platform 2017-06-22
AlsaChim–Shimadzu: investment, 201706 acquisition €na of 100% of AlsaChim by Shimadzu Europe 2017-06-21
FB Health–Invent Farma/Neuraxpharm: investment, 201706 acquisition €na of FB Health by Invent Farma/Neuraxpharm (formed 8/16 by Apax Partners) 2017-06-21
Debiopharm–Almac: kinase inhibitor, 201706– license ww excl to Wee-1 kinase inhibitor programme of Almac Discovery 2017-06-20
Facio Therapies–Evotec: investment, 201706c financing round totalling €4.8m incl strategic investment by Evotec 2017-06-20
Facio Therapies–SEVERAL: investment, 201706c financing round €4.8m incl Evotec + members of intl FSHD community 2017-06-20
Idorsia–JnJ: investment, 201706 acquisition of 9.9% share in Idorsia by Cilag Holding AG via conversion of CFH135.4m convertable loan 2017-06-20
Euroimmun–PerkinElmer: investment, 201706–201712 acquisition $1.3b in cash 2017-06-19
Takeda–Wilex: antibody-drug conjugates, 201706– collab developm of ADCs using ATACs for up to 3 targets Heidelberg Pharma + Millennium 2017-06-19
TxCell–Miltenyi Biotec: lentiviral vector, 201706– supply of lentiviral vector for TxCell’s CAR-Tregs targeting transplant rejection by Lentigen 2017-06-19
Broughton Laboratories–Thermo Fisher: LC system, 201706 supply two Vanquish Flex UPLC systems coupled to TSQ Endura TQ-MS detectors 2017-06-16
Broughton Laboratories–Thermo Fisher: mass spectrometer, 201706 supply two Vanquish Flex UPLC systems coupled to TSQ Endura TQ-MS detectors 2017-06-16
GreenBone–Helsinn: investment, 201706 2nd financing round incl €2m from lead investor Helsinn Investment Fund 2017-06-16
GreenBone–SEVERAL: investment, 201706 2nd financing round incl lead investor Helsinn Investment Fund 2017-06-16
Idorsia–OTHER: investment, 201706 listing at SIX Swiss Exchange as part of acquisition of Actelion by JnJ and spin-off of Idorsia 2017-06-16
Medicxi Ventures–Alphabet: investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–EU (govt): investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–Novartis: investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–SEVERAL: investment, 201706 closing $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
TissUse–Minapharm: organ-on-a-chip technology, 201706– license for HuALN platform for Multi-Organ-Chip applications from ProBioGen 2017-06-15
Bayer–China (govt): wheat breeding, 201706– collab 2y with SIBS + SIPPE to improve wheat yields via improved photosynthetic efficiency 2017-06-14
Pfizer–Basilea: isavuconazole, 201706– license CHF70m upfront + $427m milestones + royalties for prod + sales in Europe + RU + TR + IL 2017-06-14
Selexis–JSR Corp: investment, 201706 acquisition €na of Selexis SA by JSR Life Sciences 2017-06-14
Centogene–Careventures: investment, 201706 financing round Series A totalling €25m incl co-investor Careventures 2017-06-13
Centogene–Crédit Mutuel-CIC: investment, 201706 financing round Series A totalling €25m incl co-investor CIC Capital 2017-06-13
Centogene–DPE Deutsche Private Equity: investment, 201706 financing round Series A totalling €25m incl co-investor DPE 2017-06-13
Centogene–SEVERAL: investment, 201706 financing round Series A €25m led by TVM Capital + incl DPE + Careventures + CIC Capital 2017-06-13
Centogene–TVM: investment, 201706 financing round Series A totalling €25m incl lead investor TVM Capital Life Science 2017-06-13
CureVac–TiberendStrategic Advisors: public relations, 201706 service existent by Tiberend 2017-06-13
4SC–SEVERAL: investment, 201706–201707 cash capital increase €41m with 11.68m new shares at €3.5/share 2017-06-12
Teneobio–Selexis: cell line development, 201706– supply service access to SUREtechnology platform to develop cell expression of UniAbs 2017-06-12
Lilly–Nordic Bioscience: antidiabetic, 201706– strategic collab $55m upfront + milestones + royalties ww rights to develop DACRAs from KeyBioscience 2017-06-08
Grünenthal–AstraZeneca: zolmitriptan, 201706 acquisition ww rights excl JP to Zomig $200m upfront + $102m milestones by Grünenthal 2017-06-07
next pagenext page 1 2 3 ... 10 11 12 ... 54 55 56  next pagenext page



Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top